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Multiple intracranial tuberculomas in a 
non-immunocompromised patient 
Cliiz Microbiol Infect 1997; 3: 574-576 
Tuberculous involvement of the central nervous system 
usually appears as tuberculous meningitis or tuber- 
culoma, which often presents as a single intracranial 
lesion. Multiple intracranial tuberculomas can also be 
encountered. We report a case of 38 intracranial tuber- 
culoinas in a non-immunocompronlised patient. 
A 33-year-old Laotian man, resident in France for 
7 years, was admitted to hospital with a 2-month 
history of headache, anorexia and sleep disturbances. 
Treatment with tricyclic antidepressants and benzo- 
diazepines had been instituted 3 weeks before, with 
no effect. O n  admission the patient was drowsy, un- 
cooperative and unresponsive. His temperature was 
38.6OC. Examination showed a right Babinski sign; 
there was no stiff neck, ataxia or visual disturbance. 
Hematologic and biochemical tests were normal except 
for an erythrocyte sedimentation rate of 66 mm/h and 
an alkaline phosphatase level of 173 U/L. Tuberculin 
test and human immunodeficiency virus serology were 
negative. Chest X-ray showed diffuse reticulonodular 
infiltrates. 
Contrast-enhanced computerized tomography (CT) 
scan of the head revealed multiple solid and ring- 
enhancing lesions, both supra- and infratentorial. At 
lumbar puncture, the cerebrospinal fluid (CSF) was 
clear and contained leukocytes at 53/mm3 (segmented 
cells 45%, lymphocytes 45%) with a protein level 
1.7 g/L, and a glucose level of 0.6 minol/L (blood 
glucose: 5.6 mmol/L); no acid-alcohol-fast bacilli 
(AAFB) were seen. 
AAFB were detected in the sputum. A diagnosis of 
miliary tuberculosis with cerebral tuberculomas was 
made and a four-drug daily regimen was given with 
isoniazid 300 mg, rifampicin 600 mg, pyrazinamide 
2000 mg and ofloxacin 600 mg associated with pred- 
nisolone 60 mg daily. Initial magnetic resonance (MR) 
imaging demonstrated 20 supratentorial and 18 infra- 
tentorial lesions, showing nodular or ring enhancement 
after gadolinium (Figures 1 and 2). Percutaneous biopsy 
of the liver demonstrated granulomatous infiltration. 
After 6 weeks of incubation, sputum cultures grew 
Mycobacterium tuberculosis, which was sensitive to all the 
first-line antituberculous drugs. Cultures from liver and 
CSF were negative for M .  tuberculosis. 
After 2 months of treatment, headaches had re- 
solved but changes in mental status persisted. Cerebral 
MR imaging showed persistence of many lesions. 
Pyrazinamide and ofloxacin were discontinued. Over 
the next 6 months, patient had complete resolution 
of his neurologic signs and miliary shadowing dis- 
appeared from the chest X-ray. Prednisolone was 
gradually discontinued. After 12 months of medical 
management, follow-up MR examination showed 
regression of most tuberculomas, and persistence of 
three periventricular tuberculomas, whose size, how- 
ever, had clearly decreased. 
Diagnosis of intracranial tuberculoma has in the 
past been confirmed either at  surgery or at autopsy [l]. 
Since the advent of CT, a large number of reported 
cases have concerned one, sometimes two or three, 
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Figure 1 Contrast-enhanced coronal T1-weighted MR 
shows multiple nodular and ring-enhancing lesions. Note 
the iiicnirigeal basilar enhancement. 
space-occupying lesions. The clinical picture usually 
includes seizures and severe headaches, sometimes 
associated with neurologic defects and/or impaired 
consciousness. CT scan reveals an intracranial mass 
lesion with ring enhancement, marked surrounding 
edema and occasionally hydrocephalus [2,3). Only 
about 30% of patients show evidence of active extra- 
cranial tuberculosis [4], and CSF analysis is frequently 
normal, making definite diagnosis difficult. 
Lhcovery of multiple intracranial lesions on neuro- 
imaging, as in our patient, can be an alternative pre- 
sentation, with an increasing frequency since the wider 
use of MR imaging [5]. Diffuse cerebral involvement 
is in most of the cases part of a disseminated disease 
and can be its first manifestation, as in this case. In 
comparison with the large number of lesions, the 
disease can occur as a relatively silent clinical picture, 
including slight cognitive changes and/or subtle head- 
aches over many weeks or months [6,7]. 
Neuroimaging can exhibit two radiologic patterns. 
Both were present in this patient, where large (>2  cm) 
ring-enhancing masses coexisted with sniall (<2  cm) 
Figure 2 Axial T2-weighted MR demonstrates thrcc 
perivcntricular lesions, showing hyperintenw central 
necrosis and hypointense granuloma rim. Note the 
alternation of hyper- and hypointense rings in the thick- 
ness of thc tuberculoma wall. Compression of ventricles 
and moderate surrounding edenia are seen. 
uniformely enhancing nodular lesions [2,6,7). These 
latter may be very numerous (as many as several dozen), 
particularly on MR imaging [5], representing a real 
cerebral niiliary picture {7]. Surrounding edema is 
generally moderate, but the large number of lesions 
can account for radiologic signs of raised intracranial 
pressure, as in this report. 
It has been recently denlotistrated that the radio- 
logic features reflect the pathologic changes found 
in tuberculonias [Sl. Tubercular granuloma is a lesion 
particularly rich in macrophages and giant cells, pro- 
ducing free radicals during active phagocytosis. This 
accounts for moderately high attenuation on CT scan 
and, especially, a low-intensity signal on T2-weighted 
MR imaging, highly characteristic o f  a granulomatous 
origin. In large lesions, central caseating necrosis gives 
a bright central core on T2-weighted images. Con- 
junction with high-intensity surrounding edema can 
give a target appearance. Caseating necrosis can also 
be present in the thickness of the granuloma wall, 
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accounting for characteristic alternating rings of hypo- 
and hyperintensity on T2-weighted images [9,10]. 
The large number of cerebral lesions results from 
widespread hernatogenous dissemination, as attested by 
the frequency of extracranial involvement: the lung is 
most often involved [6], but other tissues may be con- 
cerned, e.g. liver, bone, skin and epididymis. However, 
associated meningitis is far from frequent [ l l ] .  Extra- 
cranial localizations usually provide bacteriologic and/ 
or histologic coilfirmation of diagnosis, when, as in this 
case, the pathogen is not isolated from the CSE 
Given antituberculous therapy, patients usually make 
a good recovery within a few months [3,7]. As in cases 
of single tuberculoma, adjunctive therapy with steroids 
rapidly improves neurologic symptoms in patients 
with marked brain edema [6]. In our patient, clinical 
recovery was obtained after 8 months, but persistence 
of M R  abnormalities led to a prolonged treatment. 
This evolution is not unusual. Indeed, while extra- 
neurologic manifestations and most intracranial lesions 
regress, some of them, particularly the large ones, 
can persist or enlarge [3]. In most cases, however, a 
prolonged course of antibiotic therapy for a continuous 
total period of 18 or 24 months is successful [12,13]. 
In conclusion, this case demonstrates a particular 
type of cerebral tuberculous involvement, very different 
from classic single tuberculoma. Multiple intracranial 
tuberculomas are paradoxically associated with few 
neurologic signs. The search for the frequently associated 
extracranial involvement is an important step in diag- 
nosis; this can be strongly suggested by CT and M R  
findings. The slow improvement in clinical and especially 
radiologic abnormalities with antituberculous therapy 
suggests that a prolonged treatment course and routine 
neuroimaging follow-up may be necessary. 
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Reduced susceptibility to quinolones in Salmonella typhi 
acquired in Europe: a clinical failure of treatment 
Clin Microbiol Infect 1997; 3: 576-577 
Multidrug-resistant Salmonella typhi is becoming a 
problem in developing and in developed countries. 
Third-generation cephalosporins and fluoroquinolones 
have become the treatment of choice. Fluoroquino- 
lones reduce the duration of fever, the duration of 
treatment and the prevalence of chronic intestinal 
carriage, and they can be administered orally. Among 
fluoroquinolones, ciprofloxacin is the most active: 
the ranges from 0.007 to 0.012 pg/mL [1,2] or 
0.015 pg/mL according to other authors [3]. Quino- 
lone-resistant S. typhi strains were first described in 
1988 in India [4,5]. All cases reported from European 
countries have concerned patients infected in Asia [6]. 
